Analgesia After Cesarean Section

May 24, 2011 updated by: Seoul National University Bundang Hospital
Magnesium sulphate is the first line therapy for the management of preeclampsia and eclampsia in obstetrics. Perioperative administration of magnesium sulphate has been proved to be an effective as an analgesic adjuvant. The investigators evaluated the analgesic effect of magnesium in parturients undergoing Cesarean section.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Actual)

503

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Korea, Republic of
    • Gyeonggi
      • Seongnam, Gyeonggi, Korea, Republic of
        • Seoul National University Bundang Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 50 years (ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Sampling Method

Non-Probability Sample

Study Population

medical record review

Description

Inclusion Criteria:

  • parturients undergoing Cesarean section

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Group N
parturients who had undergone Cesarean section under the diagnosis of non-preeclampsia
Group P
parturients who had undergone Cesarean section under the diagnosis of preeclampsia
Drug: Magnesium Sulphate
Magnesium sulphate was infused for the management of preeclampsia at perioperative period.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Change of numeric rating scale (NRS) of postoperative pain during postoperative period
Time Frame: postoperative 1, 2, 3, and 4 day
postoperative 1, 2, 3, and 4 day

Secondary Outcome Measures

Outcome Measure
Time Frame
incidence of stopping of intravenous PCA during postoperative 4 days
Time Frame: during postoperative 4 days
during postoperative 4 days
serum magnesium level of group P
Time Frame: preoperative 1 h and postoperative 1 day
preoperative 1 h and postoperative 1 day

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Seoul National University Bundang Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

December 1, 2010

Primary Completion (ACTUAL)

March 1, 2011

Study Completion (ACTUAL)

March 1, 2011

Study Registration Dates

First Submitted

May 17, 2011

First Submitted That Met QC Criteria

May 24, 2011

First Posted (ESTIMATE)

May 25, 2011

Study Record Updates

Last Update Posted (ESTIMATE)

May 25, 2011

Last Update Submitted That Met QC Criteria

May 24, 2011

Last Verified

May 1, 2011

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Mg_section

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pregnancy

Clinical Trials on Magnesium Sulphate

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Djibouti

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe